Voultsos Polychronis P, Taniskidou Anna-Maria I
Laboratory of Forensic Medicine and Toxicology, Department of Medicine, School of Health Sciences, Aristotle University, Greece.
Afr J Reprod Health. 2021 Oct;25(5):161-178. doi: 10.29063/ajrh2021/v25i5.17.
The COVID-19 pandemic has led to challenges in fertility preservation practices and has led to ethical issues, especially in developing countries. This paper provides a systematic review on this topic. At the beginning of the pandemic, several countries issued directions to suspend fertility treatments except among cancer patients. However, fertility preservation practices resumed gradually. The pandemic has evoked three major issues. First, many voices call for treating infertility as an essential medical condition in individual cases. There is no or negligible risk of transmission of COVID-19 through fertility treatment procedures or pregnancy. Second, there are weaknesses in health systems, especially in African countries. Third, there is enhanced discrimination and, in particular, a need to seriously consider inequality and social stratification in Africa. Oncofertility practices may be unevenly provided. The use of telemedicine to reduce nonessential contacts and the role of the Oncofertility Consortium in developing countries are highlighted.
新冠疫情给生育力保存实践带来了挑战，并引发了伦理问题，尤其是在发展中国家。本文对该主题进行了系统综述。在疫情初期，几个国家发布指示，暂停除癌症患者之外的生育治疗。然而，生育力保存实践逐渐恢复。疫情引发了三个主要问题。第一，许多声音呼吁在个别情况下将不孕症视为一种基本医疗状况。通过生育治疗程序或怀孕感染新冠病毒的风险不存在或可忽略不计。第二，卫生系统存在薄弱环节，尤其是在非洲国家。第三，歧视加剧，特别是在非洲，需要认真考虑不平等和社会分层问题。肿瘤生育实践的提供可能不均衡。强调了利用远程医疗减少不必要接触以及肿瘤生育联盟在发展中国家所发挥的作用。
